CEO: James A. Joyce.

Revenue: $1.36 million as of March 31, 2012; $ 0.00 as of March 31, 2011.

Net loss: $8.11 million as of March 31, 2012; $5.71 million as of March 31, 2011.

No. of local employees: Nine.

Headquarters: San Diego.

Year founded: 1999.

Stock symbol and exchange: AEMD on the OTC Bulletin Board.

Company description: It creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions.

Key factors for success: Hemopurifier commercialization, new contract awards, and the advancement of clinical research programs that support infectious disease and cancer indications.

Aethlon Medical Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129